Related Experiment Videos
Turner syndrome: don't forget the vulva
Dimitrios Haidopoulos1, George Bakolas1, Lina Michala1
1Department of Obstetrics and Gynecology, Alexandra Hospital, University of Athens , 80 Vas Sofias Avenue, Athens , Greece.
Endocrinology, Diabetes & Metabolism Case Reports
|June 3, 2016
Summary
Women with Turner syndrome (TS) have a higher risk of developing lichen sclerosus (LS), a condition that can lead to vulvar cancer. Regular screening for LS and vulvar cancer is recommended for adult TS patients.
Area of Science:
- Gynecology
- Autoimmune Diseases
- Oncology
Background:
- Turner syndrome (TS) is associated with an increased prevalence of autoimmune conditions, including lichen sclerosus (LS), estimated at 17%.
- Lichen sclerosus (LS) is a recognized precursor to the development of vulvar cancer.
- Vulvar cancer risk is a significant concern in women with TS and LS.
Purpose of the Study:
- To highlight the association between Turner syndrome, lichen sclerosus, and vulvar cancer.
- To emphasize the importance of regular vulvar screening in adult women with TS.
- To present a case of vulvar cancer in a patient with a history suggestive of LS.
Main Methods:
- Case presentation of a 44-year-old woman with vulvar cancer and underlying lichen sclerosus.
- Review of the known link between TS and autoimmune conditions like LS.
- Discussion of clinical presentation, histology, and management recommendations.
Main Results:
- The case confirmed squamous cell carcinoma with underlying LS in a patient with a history of pruritus.
- LS is a known precursor to vulvar cancer, and TS patients have an increased risk of developing LS.
- Early detection and monitoring are crucial for managing LS and preventing vulvar cancer progression.
Conclusions:
- Patients with Turner syndrome (TS) are at increased risk for developing lichen sclerosus (LS).
- Lichen sclerosus (LS) is a known precursor to vulvar cancer.
- Annual vulvar screening and patient awareness of symptoms are recommended for TS women with LS to mitigate vulvar cancer risk.